Funding for this research was provided by:
Institut National Du Cancer (B409)
Received: 19 May 2020
Accepted: 5 March 2021
First Online: 17 March 2021
: The study was approved by the Institutional Review Board of INSERM (IRB Inserm n°IRB0000388 FWA00005831) and the National Commission for Data Protection and Liberties (CNIL n° 909216), and registered at: ExternalRef removed. Electronic consent was obtained from each participant of the trials.
: Not applicable.
: The authors have no competing interests.